Acta Med. 2014, 57: 142-150
https://doi.org/10.14712/18059694.2015.79
NANOTECHNOLOGY – NEW TRENDS IN THE TREATMENT OF BRAIN TUMOURS
Crossref Cited-by Linking
- Singh Sukhbir, Rani Hema, Sharma Neelam, Behl Tapan, Zahoor Ishrat, Makeen Hafiz A., Albratty Mohammed, Alhazm Hassan A., Aleya Lotfi: Targeting multifunctional magnetic nanowires for drug delivery in cancer cell death: an emerging paradigm. Environ Sci Pollut Res 2023, 30, 57219. <https://doi.org/10.1007/s11356-023-26650-w>
- Liu Jie, Guo Zhen-Ni, Yan Xiu-Li, Yang Yi, Huang Shuo: Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1. Front. Aging Neurosci. 2021, 13. <https://doi.org/10.3389/fnagi.2021.755392>
- Kumar Ladi Alik, Pattnaik Gurudutta, Satapathy Bhabani Sankar, Swapna S, Mohanty Dibyalochan: Targeting to Brain Tumor. Journal of Pharmacy and Bioallied Sciences 2021, 13, 172. <https://doi.org/10.4103/jpbs.JPBS_239_20>
- Gaikwad Puja S, Banerjee Rinti: Nanotechnology-based Strategies As Novel Therapies in Gliomas. Ther. Deliv. 2018, 9, 571. <https://doi.org/10.4155/tde-2018-0022>
- Escalona-Rayo Oscar, Fuentes-Vázquez Paulina, Leyva-Gómez Gerardo, Cisneros Bulmaro, Villalobos Rafael, Magaña Jonathan J., Quintanar-Guerrero David: Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process. Drug Development and Industrial Pharmacy 2017, 43, 871. <https://doi.org/10.1080/03639045.2017.1281949>
- Gourdon Genevieve, Meola Giovanni: Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS. Front. Cell. Neurosci. 2017, 11. <https://doi.org/10.3389/fncel.2017.00101>
- Ma Dan-Dan, Yang Wan-Xi: Engineered nanoparticles induce cell apoptosis: potential for cancer therapy. Oncotarget 2016, 7, 40882. <https://doi.org/10.18632/oncotarget.8553>
- Valdés Pablo A., Roberts David W., Lu Fa-Ke, PhD, Golby Alexandra: Optical technologies for intraoperative neurosurgical guidance. FOC 2016, 40, E8. <https://doi.org/10.3171/2015.12.FOCUS15550>